Leap Therapeutics Inc. (LPTX)
NASDAQ: LPTX
· Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM
Leap Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.2 | -1.92 | -1.46 | -0.91 | -1.34 | -2.24 | -0.68 | -0.86 | -0.27 | -1.05 | -1.57 | -1.83 | -4.89 | -8.49 | -7.04 | -3.29 | -3.97 |
PEG Ratio | n/a | 0.12 | 0.11 | n/a | -0.12 | 0.23 | 0.02 | 0.01 | -0.00 | 0.04 | 0.14 | -0.02 | 0.93 | 0.26 | -0.52 | -0.79 | -0.11 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 176.23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 977.25 | 836.42 | 334.08 | 386.98 |
PB Ratio | 0.60 | 3.39 | 2.16 | 1.11 | 1.57 | 1.86 | 0.52 | 0.55 | 1.55 | 0.87 | 1.42 | 1.56 | 2.01 | 3.40 | 2.68 | 4.19 | 3.78 |
P/FCF Ratio | -0.87 | -7.66 | -6.79 | -5.35 | -4.79 | -10.76 | -3.55 | -4.52 | -3.46 | -3.92 | -8.13 | -10.62 | -17.21 | -34.2 | -38.71 | -16.16 | -16.9 |
P/OCF Ratio | -0.87 | -7.66 | -6.79 | -5.35 | -4.79 | -10.76 | -3.55 | -4.52 | -3.46 | -3.92 | -8.13 | -10.62 | -17.21 | -34.2 | -38.71 | -16.16 | -16.9 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -16.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.58 | -21.61 | -20.67 | -22.9 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Quick Ratio | 2.41 | 3.41 | 3.97 | 5.10 | 5.38 | 5.64 | 7.41 | 7.98 | 10.15 | 6.05 | 6.82 | 8.88 | 14.29 | 11.82 | 11.11 | 4.47 | 5.92 |
Current Ratio | 2.41 | 3.41 | 3.97 | 5.10 | 5.38 | 5.64 | 7.41 | 7.98 | 10.15 | 6.05 | 6.82 | 8.88 | 14.29 | 11.70 | 11.11 | 4.47 | 5.92 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.01 | 0.01 |
Interest Coverage | 2.65K | n/a | n/a | n/a | n/a | -17.17 | n/a | n/a | n/a | -2.79K | -1.39K | -994.12 | -506.29 | -5.24K | -1.35K | -601.63 | -655.14 |
Return on Equity | -0.74 | -0.44 | -0.37 | -0.31 | -0.29 | -0.21 | -0.19 | -0.16 | -1.45 | -0.21 | -0.23 | -0.21 | -0.1 | -0.1 | -0.1 | -0.32 | -0.24 |
Return on Assets | -0.44 | -0.31 | -0.28 | -0.25 | -0.24 | -0.17 | -0.16 | -0.14 | -0.38 | -0.17 | -0.19 | -0.19 | -0.1 | -0.09 | -0.09 | -0.25 | -0.2 |
Return on Invested Capital | -0.76 | -0.45 | -0.38 | -0.32 | -0.31 | -0.26 | -0.21 | -0.17 | -0.43 | -0.24 | -0.23 | -0.21 | -0.1 | -0.1 | -0.1 | -0.32 | -0.23 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -19.66 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.77 | -29.7 | -25.4 | -24.36 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -19.66 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.83 | -29.7 | -25.4 | -24.36 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -23.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -27.97 | -32.37 | -25.67 | -24.46 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -20.23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.25 | -29.5 | -24.99 | -24.3 |